Emma Ciafaloni, MD, Neurology, Rochester, NY, Highland Hospital

EmmaCiafaloniMD

Neurology Rochester, NY

Neuromuscular Medicine, Vascular Neurology

Associate Professor, Neurology, University of Rochester School of Medicine & Dentistry

Dr. Ciafaloni is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Ciafaloni's full profile

Already have an account?

Education & Training

  • Duke University Hospital
    Duke University HospitalResidency, Neurology, 1996 - 1998
  • University of Milan Faculty of Medicine
    University of Milan Faculty of MedicineClass of 1989

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2002 - 2022
  • VA State Medical License
    VA State Medical License 2001 - 2002
  • NC State Medical License
    NC State Medical License 1999 - 2003
  • American Board of Psychiatry and Neurology Neurology
  • American Board of Psychiatry and Neurology Neuromuscular Medicine

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Implementation of Duchenne Muscular Dystrophy Care Considerations  
    Emma Ciafaloni, Christopher Cunniff, AAP News

Authored Content

  • Implementation of Duchenne Muscular Dystrophy Care ConsiderationsJuly 2018

Press Mentions

  • COVID-19: Guidelines for Myasthenia Gravis Management and Other Neuromuscular Disorders
    COVID-19: Guidelines for Myasthenia Gravis Management and Other Neuromuscular DisordersMay 21st, 2020
  • Where There Is Debate on the ‘Persuasive Evidence’ That Exon-Skipping Therapies Work for Duchenne Muscular Dystrophy
    Where There Is Debate on the ‘Persuasive Evidence’ That Exon-Skipping Therapies Work for Duchenne Muscular DystrophyAugust 15th, 2019
  • New Gene Therapy Poised to Transform Care for Spinal Muscular Atrophy
    New Gene Therapy Poised to Transform Care for Spinal Muscular AtrophyJune 6th, 2019
  • Join now to see all

Grant Support

  • Trial To Assess The Efficacy &Safety Of MMF In Subjects With Myasthenia GravisNational Center For Research Resources2005
  • Causes Of Excessive Sleepiness In Myotonic DystrophyNational Center For Research Resources2004–2005
  • A Clinical Trial Of Cellcept In The Treatment Of Myasthenia GravisNational Center For Research Resources2004–2005

Professional Memberships

Hospital Affiliations